91599-86-9 Usage
Uses
Used in Pharmaceutical Industry:
(3S,5R)-1-benzyl-3,5-diMethylpiperidin-4-ol is used as a pharmaceutical compound for its potential analgesic and anesthetic properties. (3S,5R)-1-benzyl-3,5-diMethylpiperidin-4-ol's unique structure and stereochemistry allow it to interact with specific biological targets, offering potential therapeutic benefits in pain management and surgical procedures.
Used in Drug Development:
(3S,5R)-1-benzyl-3,5-diMethylpiperidin-4-ol serves as a key intermediate in the synthesis of various pharmaceutical agents. Its unique functional groups and stereochemistry make it a valuable building block for the development of new drugs with improved efficacy and selectivity.
Used in Medicinal Chemistry Research:
As a chiral compound with a piperidinol structure, (3S,5R)-1-benzyl-3,5-diMethylpiperidin-4-ol is utilized in medicinal chemistry research to explore its binding affinity, selectivity, and mechanism of action on different biological targets. This research can lead to the discovery of novel drug candidates and a better understanding of the structure-activity relationships in drug design.
Used in Chiral Chemistry:
The specific "3S,5R" stereochemistry of (3S,5R)-1-benzyl-3,5-diMethylpiperidin-4-ol makes it an important compound in chiral chemistry. It can be used to study the effects of stereochemistry on chemical reactivity, as well as to develop enantioselective synthetic methods and asymmetric catalysis.
Check Digit Verification of cas no
The CAS Registry Mumber 91599-86-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,5,9 and 9 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 91599-86:
(7*9)+(6*1)+(5*5)+(4*9)+(3*9)+(2*8)+(1*6)=179
179 % 10 = 9
So 91599-86-9 is a valid CAS Registry Number.
91599-86-9Relevant academic research and scientific papers
1-benzyl-3,5-dimethyl-4-piperdyl ester of a Hantzsch dihydropyridine
-
, (2008/06/13)
The compound of the formula STR1 is disclosed to have a less rapid decrease in blood pressure in its use as an antihypertensive.
